Medicine & Life Sciences
pitavastatin
100%
Hyperlipidemias
64%
Dyslipidemias
62%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
61%
LDL Cholesterol
38%
United States Food and Drug Administration
21%
Cytochrome P-450 Enzyme System
20%
B 31
18%
Cholesterol
15%
Cardiovascular Diseases
15%
Pravastatin
14%
Lipids
13%
Phase III Clinical Trials
12%
Atorvastatin
12%
Simvastatin
12%
Cytochrome P-450 CYP3A
12%
Apolipoproteins B
11%
Erythromycin
11%
Enzymes
11%
Rifampin
11%
Risk Reduction Behavior
10%
Therapeutics
10%
Drug Interactions
10%
Cyclosporine
9%
Oxidoreductases
9%
HDL Cholesterol
9%
Triglycerides
8%
Cause of Death
8%
Myocardial Infarction
7%
Age Groups
7%
Guidelines
6%
Morbidity
6%
Blood Vessels
6%
Pharmaceutical Preparations
4%